Chao Xingjuan 4

4 · Ceribell, Inc. · Filed Jun 10, 2026

AI-generated summary of this filing

Updated Jun 10, 2026

Ceribell (CBLL) CEO Chao Xingjuan Sells Shares, Exercises Options

What Happened

Chao Xingjuan, Ceribell’s President & CEO and a director, exercised stock options and sold company shares on June 8, 2026. She acquired 25,000 shares by exercising options (1,446 + 23,554) at $4.70 per share (total cost $117,500) and sold a total of 39,000 shares (14,000 + 1,446 + 23,554) in open-market transactions at a weighted average price of $18.33, generating proceeds of about $714,870. The transactions were effected under a Rule 10b5-1 trading plan.

Key Details

Transaction date: 2026-06-08; Form 4 filed 2026-06-10 (timely).
Exercise (code M): 1,446 shares @ $4.70 ($6,796) and 23,554 shares @ $4.70 ($110,704) — total exercise cost $117,500.
Sales (code S): 14,000 shares ($256,620), 1,446 shares ($26,505), 23,554 shares ($431,745) — total proceeds $714,870; weighted avg sale price reported as $18.33 (individual sales ranged $18.15–$18.75).
Post-transaction beneficial ownership: not specified in the provided excerpt.
Notable footnotes: trades effected pursuant to a Rule 10b5-1 plan (F1); weighted-average sale price with per-share range (F2); reporting person is co‑trustee of a trust and disclaims beneficial ownership except for pecuniary interest (F3–F4); some options vesting and vesting schedule/fully vested notes present (F5–F6).
No late filing flag in the provided data.

Context

This is a common "exercise and sell" sequence: options were exercised (acquiring shares at $4.70) and the resulting shares were sold in the market the same day — effectively a cash‑out of option value rather than a fresh purchase indicating bullishness. The 10b5-1 plan note means the sales were preplanned and automated per an adopted trading plan.

Form 4

Period: 2026-06-08

DirectorPresident and CEO

Transactions

Sale
Common Stock
[F1][F2]
2026-06-08$18.33/sh−14,000$256,620→ 816,317 total
Exercise/Conversion
Common Stock
[F1]
2026-06-08$4.70/sh+1,446$6,796→ 817,763 total
Sale
Common Stock
[F1][F2]
2026-06-08$18.33/sh−1,446$26,505→ 816,317 total
Exercise/Conversion
Common Stock
[F1]
2026-06-08$4.70/sh+23,554$110,704→ 839,871 total
Sale
Common Stock
[F1][F2]
2026-06-08$18.33/sh−23,554$431,745→ 816,317 total
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F5]
2026-06-08−1,446→ 290,156 total
Exercise: $4.70Exp: 2033-02-16→ Common Stock (1,446 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
[F1][F6]
2026-06-08−23,554→ 101,477 total
Exercise: $4.70Exp: 2033-02-16→ Common Stock (23,554 underlying)

Holdings

Footnotes (6)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.15 to $18.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
[F3]The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
[F4]The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
[F5]The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
[F6]The stock option is fully vested and currently exercisable.

Signature

/s/ Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao|2026-06-10

1 file